Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOST Therapy in Knee Osteoarthritis
NCT05280002Phase 2Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jan 2018
- Primary completion
- Oct 2021
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in knee osteoarthritis (OA) (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoints: Changes in pain intensity at 24 weeks, Changes in Physical functioning of knee joints at 24 weeks and 1 more. Started Jan 2018; status: completed.
02
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05280002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05280002.